However, clinical therapies targeting inflammatory cytokines such as tumor necrosis factor (TNF)-α and interleukin (IL)-1β antagonists have shown no benefit or, in some cases, have worsened survival, suggesting a complex pathological mechanism for sepsis (Echtenacher et al, 2003; Moore et al, 2003). This evidence concerns the gene TNF and Sepsis.